Salarius Pharmaceuticals, Inc. (SLRX)

NASDAQ: SLRX · IEX Real-Time Price · USD

0.499

-0.009 (-1.77%)

At close: Apr 25, 2024, 3:53 PM

0.510

+0.011 (2.20%)

After-hours: Apr 25, 2024, 5:01 PM EDT

Salarius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	2	3	3	22	18	15	6	63	95	223
Market Cap Growth	-	-26.56%	-84.44%	24.07%	17.42%	157.99%	-90.50%	-33.90%	-57.53%	-
Enterprise Value	-3	-3	-9	-7	7	12	-0	62	34	132
PE Ratio	-0.20	-0.20	-0.11	-1.75	-2.33	-2.22	-3.57	-34.09	-2.40	-7.67
PS Ratio	-	-	-	12.18	3.45	4.44	3.06	33.87	93.88	-
PB Ratio	0.43	0.48	0.34	0.58	0.82	1.45	-4.69	-21.62	1.60	2.42
P/FCF Ratio	-0.20	-0.20	-0.20	-2.20	-1.75	-1.33	1.43	-43.07	-2.91	-10.63
P/OCF Ratio	-0.20	-0.20	-0.20	-2.20	-1.75	-1.33	1.43	-43.07	-2.96	-10.77
EV/Sales Ratio	-	-	-	-3.70	1.42	3.50	-0.09	33.59	33.33	-
EV/EBITDA Ratio	0.24	0.24	0.27	0.53	-1.01	-1.78	0.10	-35.94	-0.86	-4.54
EV/EBIT Ratio	0.24	0.24	0.27	0.53	-1.01	-1.75	0.10	-35.60	-0.85	-4.53
EV/FCF Ratio	0.24	0.24	0.49	0.67	-0.72	-1.05	-0.04	-42.72	-1.03	-6.28
Debt / Equity Ratio	0.05	0.05	-	-	0.02	0.05	-	-	-	-
Debt / EBITDA Ratio	-0.02	-0.02	-	-	-0.07	-0.07	-	-	-	-
Debt / FCF Ratio	-0.02	-0.02	-	-	-0.05	-0.04	-	-	-	-
Quick Ratio	4.54	4.54	3.22	14.60	5.40	1.13	0.78	0.31	15.74	32.12
Current Ratio	5.02	5.02	3.40	14.29	5.70	1.42	0.81	0.31	16.06	32.40
Asset Turnover	0	0	0	0.04	0.24	0.32	0.12	0.05	0.01	0
Return on Equity (ROE)	-198.00%	-198.00%	-138.50%	-29.00%	-39.90%	-82.30%	-14.80%	-5.70%	-55.60%	-28.80%
Return on Assets (ROA)	-135.20%	-135.20%	-122.10%	-27.90%	-35.80%	-63.50%	-10.50%	-5.00%	-52.90%	-28.10%
Return on Capital (ROIC)	-231.22%	-231.22%	-306.62%	-33.09%	-34.40%	-74.57%	132.53%	60.30%	-67.24%	-31.69%
Earnings Yield	-549.36%	-489.95%	-906.79%	-56.99%	-42.91%	-45.10%	-28.01%	-2.93%	-41.62%	-13.04%
FCF Yield	-562.65%	-501.81%	-504.79%	-45.53%	-57.12%	-75.30%	70.07%	-2.32%	-34.36%	-9.41%
Buyback Yield / Dilution	-53.66%	-53.66%	-28.40%	-165.53%	-376.61%	-112.33%	-34.15%	-76.72%	-15.68%	-
Total Shareholder Return	-53.66%	-53.66%	-28.40%	-165.53%	-376.61%	-112.33%	-34.15%	-76.72%	-15.68%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).